PPMX-T003
N/A
Report date: 2023/06/15 20:00:37
Base Information
Drug NamePPMX-T003
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPerseus Proteomics Inc
China Registration ClassN/A
Develop Information
Active CompaniesTokai UniversityHiroshima University HospitalNagoya University +[7]
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A